Discontinued drugs in 2008: endocrine and metabolic

被引：11
|
作者：
Colca, Jerry R. [1 ]
机构：
[1] Metab Dis Dev Co, Kalamazoo, MI 49007 USA
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2009年 / 18卷 / 09期
关键词：
anti-atherosclerosis; diabetes; discontinued drugs; hypolipidemic; obesity; GLUCOSE; INHIBITOR; THERAPY; SGLT2;
D O I：
10.1517/13543780903132673
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This perspective summarizes key compounds from the endocrine and metabolic area that were discontinued during the calendar year 2008. This is a continuation in a series of perspectives of each of the editorial areas summarized by Expert Opinion on Investigational Drugs. The candidates covered in this summary were being developed for the treatment of diabetes, diabetic complications, anti-atherosclerosis and obesity.
引用
收藏
页码：1243 / 1255
页数：13
相关论文
共 50 条
12345